MAP Kinase Signaling System
"MAP Kinase Signaling System" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intracellular signaling system involving the MAP kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade.
Descriptor ID |
D020935
|
MeSH Number(s) |
G02.111.820.560 G03.493.560 G04.835.560
|
Concept/Terms |
ERK1-2 Pathway- ERK1-2 Pathway
- ERK1 2 Pathway
- ERK1-2 Pathways
- Pathway, ERK1-2
- Pathways, ERK1-2
- ERK1 and ERK2 Pathway
p38 Kinase Pathway- p38 Kinase Pathway
- Kinase Pathway, p38
- Kinase Pathways, p38
- Pathway, p38 Kinase
- Pathways, p38 Kinase
- p38 Kinase Pathways
- p38 Kinase Signaling Pathway
MAP Kinase Cascade- MAP Kinase Cascade
- Cascade, MAP Kinase
- Kinase Cascade, MAP
- MAP Kinase Cascades
- MAP Kinase Modules
- MAP Kinase Module
- Module, MAP Kinase
- MAP Kinase Signaling Cascades
MEK-ERK Pathway- MEK-ERK Pathway
- MEK ERK Pathway
- MEK-ERK Pathways
- Pathway, MEK-ERK
- Pathways, MEK-ERK
JNK Pathway- JNK Pathway
- JNK Pathways
- Pathway, JNK
- Pathways, JNK
- JNK Signaling Pathway
- JNK Signaling Pathways
- Pathway, JNK Signaling
- Pathways, JNK Signaling
- Signaling Pathway, JNK
- Signaling Pathways, JNK
|
Below are MeSH descriptors whose meaning is more general than "MAP Kinase Signaling System".
Below are MeSH descriptors whose meaning is more specific than "MAP Kinase Signaling System".
This graph shows the total number of publications written about "MAP Kinase Signaling System" by people in this website by year, and whether "MAP Kinase Signaling System" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 2 | 2 | 4 |
2001 | 1 | 1 | 2 |
2002 | 5 | 4 | 9 |
2003 | 1 | 2 | 3 |
2004 | 3 | 5 | 8 |
2005 | 2 | 7 | 9 |
2006 | 3 | 8 | 11 |
2007 | 3 | 4 | 7 |
2008 | 2 | 5 | 7 |
2009 | 0 | 7 | 7 |
2010 | 2 | 3 | 5 |
2011 | 3 | 6 | 9 |
2012 | 4 | 9 | 13 |
2013 | 4 | 7 | 11 |
2014 | 2 | 16 | 18 |
2015 | 3 | 6 | 9 |
2016 | 2 | 5 | 7 |
2017 | 1 | 11 | 12 |
2018 | 6 | 6 | 12 |
2019 | 4 | 2 | 6 |
2020 | 1 | 7 | 8 |
2021 | 4 | 4 | 8 |
2022 | 1 | 2 | 3 |
2023 | 1 | 1 | 2 |
2024 | 3 | 7 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "MAP Kinase Signaling System" by people in Profiles.
-
ERK activation dynamics in maturing oocyte controls embryonic nuclear divisions in Caenorhabditis elegans. Cell Rep. 2025 Jan 28; 44(1):115157.
-
Mechanism of Marinobufagenin-Induced Hyperpermeability of Human Brain Microvascular Endothelial Cell Monolayer: A Potential Pathogenesis of Seizure in Preeclampsia. Cells. 2024 10 30; 13(21).
-
P2X7R-primed keratinocytes are susceptible to apoptosis via GPCR-G??-pERK signal pathways. J Dermatol Sci. 2024 Dec; 116(3):90-99.
-
BST2 facilitates activation of hematopoietic stem cells through ERK signaling. Exp Hematol. 2024 Dec; 140:104653.
-
Germline mutations in a G protein identify signaling cross-talk in T cells. Science. 2024 Sep 20; 385(6715):eadd8947.
-
MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Carcinogenesis. 2024 Aug 12; 45(8):582-594.
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. J Clin Invest. 2024 Jun 17; 134(15).
-
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. JCO Precis Oncol. 2024 Jun; 8:e2400103.
-
Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection. Int Immunopharmacol. 2024 Jun 15; 134:112100.
-
From mutation to management: Advancing Langerhans cell histiocytosis treatment through combination therapies. Br J Haematol. 2024 May; 204(5):1588-1589.